Atlas Trials

Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria

Clinical trial NCT07345923 · RECRUITING

Trial details

NCT number
NCT07345923
Sponsor
University Hospital, Strasbourg, France
Status
RECRUITING
Study type
OBSERVATIONAL
Infections, Enterobacteriaceae
Start date
2025-10-06
Primary completion
2027-04-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.